StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) stock

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.15−0.01 (-8.44%)

Close on Nov 18, 2026Market cap $3.16MP/E –Yield –

Mangoceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Mangoceuticals's free cash flow for the twelve months ending Dec 31, 2023 was -$7.00M. For fiscal 2023 it was -$7.00M.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$7.00M–
FY2022Dec 31, 2022-$1.39M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$1.70M–
Q3 FY2023Sep 30, 2023-$1.71M–
Q2 FY2023Jun 30, 2023-$1.78M–
Q1 FY2023Mar 31, 2023-$1.81M–
Q4 FY2022Dec 31, 2022-$690.13K–

More Mangoceuticals figures

See a number that looks wrong?